Datamonitor's October edition of the Global Healthcare Review contains news, analysis and opinions on the healthcare and pharmaceutical industry.

It covers all the major current business issues and events from across the industry, including R&D, licensing deals, alliances and joint ventures, and regulatory decisions.

Scope

• Strategic insight into the future shape of healthcare companies and markets

• The most significant healthcare industry news compiled into monthly updates, divided by sector

• Expert analysis into the implications of the month's important healthcare industry events

• Insight into the future shape of the market for players at all levels

• All the month's healthcare news in headline and summary form

Report Highlights

Out of the hundreds of topics covered in this month's review, the most important include:

* GlaxoSmithKline launched a lawsuit against a Novartis subsidiary that manufactures a generic version of its antibiotic Augmentin. GlaxoSmithKline claims the generic version is based on a type of bacteria stolen by a former employee.

* Merck's CEO calls for more private sector action to tackle AIDS epidemic. He suggested that pharmaceutical companies should join forces with United Nations Agencies, big business and governments to tackle the growing AIDS epidemic raging in southern Africa.

Reasons to Purchase

• Not only keeps you updated about industry events - it also gives you opinion and insight

• Draws upon Datamonitor analysts' extensive experience to bring you our perspective on the impact of the latest events

• Provides you with your own news archive to track company and industry progress, giving you an extensive reference to relevant events and issues

CANCER UPDATES

The most significant news in cancer R&D, compiled into monthly updates including:

Breast cancer

Lung cancer

Prostate cancer

Colorectal cancer

Other cancers

CARDIO UPDATES

The most significant news in cardiovascular R&D, compiled into monthly updates including:

Cardiac disease

Hypertension

Hyperlipidemia

Other cardiovascular

CNS UPDATES

The most significant news in CNS R&D, compiled into monthly updates including:

Alzheimer's disease

Depression

Epilepsy

Migraine

Multiple sclerosis

Other CNS

INFECTIOUS DISEASES UPDATES

The most significant news in infectious diseases R&D, compiled into monthly updates including:

HIV

Hepatitis

Bacterial infections

Fungal infections

Other infections

IDI UPDATES

The most significant news in IDI R&D, compiled into monthly updates including:

Arthritis

Diabetes

Asthma

Other respiratory

Other IDI

HEALTHCARE LICENSING UPDATES

The most significant news in healthcare licensing, compiled into monthly updates including:

• Licensing

• Alliances and joint ventures

EHEALTH UPDATES

The most significant news in eHealthcare, compiled into monthly updates including:

ePharma

ephysician

LATEST COMMENT

Expert analysis of the implications of the month's important industry events

• Sankyo: stretching Benicar further

• Lilly: no European rebirth for Xigris

• Johnson & Johnson: Cypher stent set to hit the US

• Novartis: multiple roles for Gleevec

• AstraZeneca: a nail in the coffin of EGFr inhibitor hopes

• Novuspharma: lending a hand to Micromet

• Chiron/Genentech: battling on despite Herceptin ruling

• Forest/Lundbeck: left-handed may not be much better

• GSK: stuck in the middle as regulator fights judge

• GlaxoSmithKline: bipolar filing for Lamictal

• Alzheimer's disease: drug trial comes under fire

• Cryolife: another orthopedic recall scandal

• Cipla: lobbying for more generics in South Africa

• Alternative therapies: hurting HIV regimes

• HIV treatment: non-compliance brings pitfalls without benefits

• Bayer: seeking Gamunex approval

FEATURE ANALYSIS

Analyst-written feature articles, featuring the latest insights into the industry

• Pink Viagra: revolutionizing female sexual dysfunction treatment?

• Postnatal depression: industry action long overdue

• ePharma: targeting the online health conscious

• Acute respiratory distress syndrome: searching for effective therapies

• HIV: the crisis continues

MARKET SNAPSHOTS

Insight into the future shape of the market for players at all levels

• Tumors: breast most common in 2001

• Malignant melanoma: incidence to hit 77,000 in 2010

NEWS HEADLINES - CANCER

All the month's cancer news stories in headline and summary form including:

Breast cancer

Lung cancer

Prostate cancer

Colorectal cancer

Other cancers

NEWS HEADLINES - CARDIOVASCULAR

All the month's cardivascular news stories in headline and summary form including:

Cardiac disease

Hypertension

Hyperlipidemia

Other cardiovascular

NEWS HEADLINES - CNS

All the month's CNS news stories in headline and summary form including:

Alzheimer's disease

Depression

Epilepsy

Migraine

Multiple sclerosis

Other CNS

NEWS HEADLINES - EHEALTHCARE

All the month's eHealthcare news stories in headline and summary form including:

ePharma

ePhysician

NEWS HEADLINES - INFECTIOUS DISEASES

All the month's infectious disease news stories in headline and summary form including:

HIV

Hepatitis

Bacterial infections

Fungal infections

Other infections

NEWS HEADLINES - IMMUNE DISORDERS & INFLAMMATION

All the month's IDI news stories in headline and summary form including:

Arthritis

Diabetes

Asthma

Other respiratory

Other IDI

NEWS HEADLINES - HEALTHCARE LICENSING

All the month's healthcare licensing news stories in headline and summary form including:

Licensing

Alliances and joint ventures

To order - click here!